Page last updated: 2024-10-18

dalteparin and Osteomalacia

dalteparin has been researched along with Osteomalacia in 1 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Osteomalacia: Disorder caused by an interruption of the mineralization of organic bone matrix leading to bone softening, bone pain, and weakness. It is the adult form of rickets resulting from disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis.

Research Excerpts

ExcerptRelevanceReference
"Calcifying panniculitis is a rare form of calcinosis cutis belonging to the spectrum of calciphylaxis that has almost invariably been described in patients with severe renal disturbances."2.43Calcifying panniculitis following subcutaneous injections of nadroparin-calcium in a patient with osteomalacia. ( Borradori, L; Campanelli, A; Kaya, G; Masouyé, I, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Campanelli, A1
Kaya, G1
Masouyé, I1
Borradori, L1

Reviews

1 review available for dalteparin and Osteomalacia

ArticleYear
Calcifying panniculitis following subcutaneous injections of nadroparin-calcium in a patient with osteomalacia.
    The British journal of dermatology, 2005, Volume: 153, Issue:3

    Topics: Anticoagulants; Calciphylaxis; Depression; Female; Humans; Injections, Subcutaneous; Middle Aged; Na

2005